ID STF1_BOVIN Reviewed; 461 AA. AC Q04752; DT 01-OCT-1993, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1993, sequence version 1. DT 27-MAR-2024, entry version 184. DE RecName: Full=Steroidogenic factor 1; DE Short=SF-1; DE Short=STF-1; DE AltName: Full=Adrenal 4-binding protein; DE AltName: Full=Fushi tarazu factor homolog 1; DE AltName: Full=Nuclear receptor subfamily 5 group A member 1; DE AltName: Full=Steroid hormone receptor Ad4BP; GN Name=NR5A1; Synonyms=AD4BP, FTZF1; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 120-180. RC TISSUE=Adrenal cortex; RX PubMed=8463279; DOI=10.1016/s0021-9258(18)53202-6; RA Honda S., Morohashi K., Nomura M., Takeya H., Kitajima M., Omura T.; RT "Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone RT receptor superfamily."; RL J. Biol. Chem. 268:7494-7502(1993). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] OF 13-81. RX PubMed=1406703; DOI=10.1210/mend.6.8.1406703; RA Lala D.S., Rice D.A., Parker K.L.; RT "Steroidogenic factor I, a key regulator of steroidogenic enzyme RT expression, is the mouse homolog of fushi tarazu-factor I."; RL Mol. Endocrinol. 6:1249-1258(1992). CC -!- FUNCTION: Transcriptional activator. Seems to be essential for sexual CC differentiation and formation of the primary steroidogenic tissues. CC Binds to the Ad4 site found in the promoter region of steroidogenic CC P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the CC AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR CC genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences CC for the recognition by NR5A1. The SFPQ-NONO-NR5A1 complex binds to the CC CYP17 promoter and regulates basal and cAMP-dependent transcriptional CC activity. Binds phospholipids with a phosphatidylinositol (PI) CC headgroup, in particular PI(3,4)P2 and PI(3,4,5)P3. Activated by the CC phosphorylation of NR5A1 by HIPK3 leading to increased steroidogenic CC gene expression upon cAMP signaling pathway stimulation (By CC similarity). {ECO:0000250}. CC -!- SUBUNIT: Binds DNA as a monomer. Part of a complex consisting of SFPQ, CC NONO and NR5A1. Interacts with NR0B2. Interacts with DGKQ and CDK7. CC Binds to and activated by HIPK3 (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC Q04752; O60869-1: EDF1; Xeno; NbExp=4; IntAct=EBI-850837, EBI-781310; CC -!- SUBCELLULAR LOCATION: Nucleus. CC -!- TISSUE SPECIFICITY: Adrenal, ovary, testis, placenta, adipocyte, and CC brain. CC -!- PTM: May be regulated by phosphorylation and dephosphorylation. CC -!- PTM: Acetylation stimulates the transcriptional activity. CC {ECO:0000250}. CC -!- PTM: Sumoylation reduces CDK7-mediated phosphorylation on Ser-203. CC {ECO:0000250}. CC -!- PTM: Phosphorylated on Ser-203 by CDK7. This phosphorylation promotes CC transcriptional activity (By similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR5 CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D13569; BAA02764.1; -; mRNA. DR EMBL; S45997; AAB23574.2; -; mRNA. DR PIR; A46077; A46077. DR RefSeq; NP_776828.1; NM_174403.2. DR RefSeq; XP_010808627.1; XM_010810325.2. DR AlphaFoldDB; Q04752; -. DR SMR; Q04752; -. DR IntAct; Q04752; 1. DR STRING; 9913.ENSBTAP00000011869; -. DR iPTMnet; Q04752; -. DR PaxDb; 9913-ENSBTAP00000011869; -. DR Ensembl; ENSBTAT00000011869.4; ENSBTAP00000011869.3; ENSBTAG00000009017.4. DR GeneID; 281948; -. DR KEGG; bta:281948; -. DR CTD; 2516; -. DR VEuPathDB; HostDB:ENSBTAG00000009017; -. DR VGNC; VGNC:32248; NR5A1. DR eggNOG; KOG4218; Eukaryota. DR GeneTree; ENSGT00940000153391; -. DR HOGENOM; CLU_011437_0_0_1; -. DR InParanoid; Q04752; -. DR OMA; EVTCNNL; -. DR OrthoDB; 2968690at2759; -. DR TreeFam; TF350737; -. DR Reactome; R-BTA-383280; Nuclear Receptor transcription pathway. DR Reactome; R-BTA-4090294; SUMOylation of intracellular receptors. DR Proteomes; UP000009136; Chromosome 11. DR Bgee; ENSBTAG00000009017; Expressed in theca cell and 30 other cell types or tissues. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0005654; C:nucleoplasm; IEA:Ensembl. DR GO; GO:0005634; C:nucleus; IMP:UniProtKB. DR GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IBA:GO_Central. DR GO; GO:0003682; F:chromatin binding; IEA:Ensembl. DR GO; GO:0003677; F:DNA binding; ISS:HGNC-UCL. DR GO; GO:0019899; F:enzyme binding; IEA:Ensembl. DR GO; GO:0004879; F:nuclear receptor activity; IEA:Ensembl. DR GO; GO:0003707; F:nuclear steroid receptor activity; IDA:UniProtKB. DR GO; GO:0005543; F:phospholipid binding; IEA:Ensembl. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central. DR GO; GO:0043565; F:sequence-specific DNA binding; IMP:UniProtKB. DR GO; GO:0001222; F:transcription corepressor binding; IPI:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0030325; P:adrenal gland development; IEA:Ensembl. DR GO; GO:0008585; P:female gonad development; ISS:UniProtKB. DR GO; GO:0042445; P:hormone metabolic process; IEA:Ensembl. DR GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central. DR GO; GO:0033327; P:Leydig cell differentiation; IEA:Ensembl. DR GO; GO:0001553; P:luteinization; IEA:Ensembl. DR GO; GO:0051457; P:maintenance of protein location in nucleus; IEA:Ensembl. DR GO; GO:0008584; P:male gonad development; ISS:UniProtKB. DR GO; GO:0030238; P:male sex determination; IEA:Ensembl. DR GO; GO:2000195; P:negative regulation of female gonad development; IEA:Ensembl. DR GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB. DR GO; GO:2000020; P:positive regulation of male gonad development; IEA:Ensembl. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR GO; GO:0060008; P:Sertoli cell differentiation; IEA:Ensembl. DR GO; GO:0007530; P:sex determination; ISS:UniProtKB. DR GO; GO:0009888; P:tissue development; IBA:GO_Central. DR CDD; cd07167; NR_DBD_Lrh-1_like; 1. DR CDD; cd07070; NR_LBD_SF-1; 1. DR Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1. DR Gene3D; 1.10.565.10; Retinoid X Receptor; 1. DR InterPro; IPR035500; NHR-like_dom_sf. DR InterPro; IPR016355; NR5-like. DR InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd. DR InterPro; IPR001723; Nuclear_hrmn_rcpt. DR InterPro; IPR001628; Znf_hrmn_rcpt. DR InterPro; IPR013088; Znf_NHR/GATA. DR PANTHER; PTHR24086; NUCLEAR RECEPTOR SUBFAMILY 5 GROUP A; 1. DR PANTHER; PTHR24086:SF24; STEROIDOGENIC FACTOR 1; 1. DR Pfam; PF00104; Hormone_recep; 1. DR Pfam; PF00105; zf-C4; 1. DR PIRSF; PIRSF002530; Nuc_orph_FTZ-F1; 1. DR PRINTS; PR00398; STRDHORMONER. DR PRINTS; PR00047; STROIDFINGER. DR SMART; SM00430; HOLI; 1. DR SMART; SM00399; ZnF_C4; 1. DR SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1. DR SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1. DR PROSITE; PS51843; NR_LBD; 1. DR PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1. DR PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1. PE 1: Evidence at protein level; KW Acetylation; Activator; Direct protein sequencing; DNA-binding; KW Isopeptide bond; Lipid-binding; Metal-binding; Nucleus; Phosphoprotein; KW Receptor; Reference proteome; Transcription; Transcription regulation; KW Ubl conjugation; Zinc; Zinc-finger. FT CHAIN 1..461 FT /note="Steroidogenic factor 1" FT /id="PRO_0000053728" FT DOMAIN 222..459 FT /note="NR LBD" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01189" FT DNA_BIND 10..85 FT /note="Nuclear receptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00407" FT ZN_FING 13..33 FT /note="NR C4-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00407" FT ZN_FING 49..73 FT /note="NR C4-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00407" FT REGION 116..158 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 230..461 FT /note="Important for dimerization" FT COMPBIAS 124..140 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 341 FT /ligand="a 1,2-diacyl-sn-glycero-3-phosphocholine" FT /ligand_id="ChEBI:CHEBI:57643" FT /evidence="ECO:0000250|UniProtKB:P33242" FT BINDING 436 FT /ligand="a 1,2-diacyl-sn-glycero-3-phosphocholine" FT /ligand_id="ChEBI:CHEBI:57643" FT /evidence="ECO:0000250|UniProtKB:P33242" FT BINDING 440 FT /ligand="a 1,2-diacyl-sn-glycero-3-phosphocholine" FT /ligand_id="ChEBI:CHEBI:57643" FT /evidence="ECO:0000250|UniProtKB:P33242" FT MOD_RES 34 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q13285" FT MOD_RES 38 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q13285" FT MOD_RES 72 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q13285" FT MOD_RES 203 FT /note="Phosphoserine; by CDK7" FT /evidence="ECO:0000250|UniProtKB:Q13285" FT CROSSLNK 119 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO)" FT /evidence="ECO:0000250" FT CROSSLNK 194 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO)" FT /evidence="ECO:0000250" FT CONFLICT 64..65 FT /note="Missing (in Ref. 2; AAB23574)" FT /evidence="ECO:0000305" SQ SEQUENCE 461 AA; 51613 MW; 910747C467ABBD6E CRC64; MDYSYDEDLD ELCPVCGDKV SGYHYGLLTC ESCKGFFKRT VQNNKHYTCT ESQSCKIDKT QRKRCPFCRF QKCLTVGMRL EAVRADRMRG GRNKFGPMYK RDRALKQQKK AQIRANGFKL ETGPPVGVPP PPPPPPDYML PHGLHASEPK GLASGPPAGP LGDFGAPALP MAVPSAHGPL AGYLYPAFPG RAIKSEYPEP YASPPQPGPP YGYPEPFSGG PGVPELILQL LQLEPDEDQV RARIVGCLQE PAKGRPDQPA PFSLLCRMAD QTFISIVDWA RRCMVFKELE VADQMTLLQN CWSELLVFDH IYRQIQHGKE GSILLVTGQE VELTTVAAQA GSLLHSLVLR AQELVLQLHA LQLDRQEFVC LKFLILFSLD VKFLNNHSLV KEAQEKANAA LLDYTLCHYP HCGDKFQQLL LCLVEVRALS MQAKEYLYHK HLGNEMPRNN LLIEMLQAKQ T //